Palvella Therapeutics Appoints Rare Disease Senior Executive Elaine J. Heron, PhD to Board of Directors

Palvella Therapeutics Appoints Rare Disease Senior Executive Elaine J. Heron, PhD to Board of Directors
– Dr. Heron Adds Deep Expertise in Orphan Drug Development and Commercialization –  

See more here